Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 1
2003 2
2005 2
2006 2
2007 6
2008 6
2009 4
2010 6
2011 12
2012 13
2013 8
2014 12
2015 8
2016 7
2017 7
2018 2
2019 8
2020 3
2021 12
2022 17
2023 15
2024 8

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

137 results

Results by year

Filters applied: . Clear all
Page 1
Elacestrant (oral selective estrogen receptor degrader) Versus Standard Endocrine Therapy for Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: Results From the Randomized Phase III EMERALD Trial.
Bidard FC, Kaklamani VG, Neven P, Streich G, Montero AJ, Forget F, Mouret-Reynier MA, Sohn JH, Taylor D, Harnden KK, Khong H, Kocsis J, Dalenc F, Dillon PM, Babu S, Waters S, Deleu I, García Sáenz JA, Bria E, Cazzaniga M, Lu J, Aftimos P, Cortés J, Liu S, Tonini G, Laurent D, Habboubi N, Conlan MG, Bardia A. Bidard FC, et al. Among authors: montero aj. J Clin Oncol. 2022 Oct 1;40(28):3246-3256. doi: 10.1200/JCO.22.00338. Epub 2022 May 18. J Clin Oncol. 2022. PMID: 35584336 Free PMC article. Clinical Trial.
Phase II Clinical Trial of Pembrolizumab and Chemotherapy Reveals Distinct Transcriptomic Profiles by Radiologic Response in Metastatic Triple-Negative Breast Cancer.
Wilkerson AD, Parthasarathy PB, Stabellini N, Mitchell C, Pavicic PG Jr, Fu P, Rupani A, Husic H, Rayman PA, Swaidani S, Abraham J, Budd GT, Moore H, Al-Hilli Z, Ko JS, Baar J, Chan TA, Alban T, Diaz-Montero CM, Montero AJ. Wilkerson AD, et al. Among authors: montero aj. Clin Cancer Res. 2024 Jan 5;30(1):82-93. doi: 10.1158/1078-0432.CCR-23-1349. Clin Cancer Res. 2024. PMID: 37882661 Free PMC article. Clinical Trial.
Building Quality from the Ground Up in a Cancer Center.
Babar A, Montero AJ. Babar A, et al. Among authors: montero aj. 2021 Oct 29. In: Aljurf M, Majhail NS, Koh MBC, Kharfan-Dabaja MA, Chao NJ, editors. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 14. 2021 Oct 29. In: Aljurf M, Majhail NS, Koh MBC, Kharfan-Dabaja MA, Chao NJ, editors. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 14. PMID: 36122085 Free Books & Documents. Review.
Multicriteria decision analysis in oncology.
Adunlin G, Diaby V, Montero AJ, Xiao H. Adunlin G, et al. Among authors: montero aj. Health Expect. 2015 Dec;18(6):1812-26. doi: 10.1111/hex.12178. Epub 2014 Mar 17. Health Expect. 2015. PMID: 24635949 Free PMC article. Review.
Detecting cancer: Pearls for the primary care physician.
Zeichner SB, Montero AJ. Zeichner SB, et al. Among authors: montero aj. Cleve Clin J Med. 2016 Jul;83(7):515-23. doi: 10.3949/ccjm.83a.15124. Cleve Clin J Med. 2016. PMID: 27399864 Free article. Review.
On being a doll.
Montero AJ. Montero AJ. Oncologist. 2014 Jan;19(1):100-1. doi: 10.1634/theoncologist.2013-0349. Epub 2013 Dec 4. Oncologist. 2014. PMID: 24304713 Free PMC article. No abstract available.
PET/CT Variants and Pitfalls in Breast Cancers.
Kikano EG, Avril S, Marshall H, Jones RS, Montero AJ, Avril N. Kikano EG, et al. Among authors: montero aj. Semin Nucl Med. 2021 Sep;51(5):474-484. doi: 10.1053/j.semnuclmed.2021.04.005. Epub 2021 Jun 2. Semin Nucl Med. 2021. PMID: 34088473 Review.
137 results